이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Physiomics 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Peter Sargent

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	1.1yrs
CEO 소유권	n/a
경영진 평균 재임 기간	3.2yrs
이사회 평균 재임 기간	2.5yrs

최근 관리 업데이트

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Nov 15

Recent updates

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Nov 15

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Nov 17

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Nov 16

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

Feb 08

CEO

Peter Sargent (46 yo)

1.1yrs

테뉴어

Dr. Peter Joseph Sargent is Chief Operating Officer of Physiomics Plc from September 04, 2023 and serves as its Chief Executive Officer and Director from January 22, 2024. He joined Physiomics Plc in Septe...

리더십 팀

이름	위치	테뉴어	보상	소유권
Peter Sargent	CEO, COO & Director	1.1yrs	데이터 없음	데이터 없음
David Fell	Co-Founder & Member of Scientific Advisory Board	no data	UK£2.63k	데이터 없음
Anthony Clayden	Head of Finance & Company Secretary	8.4yrs	데이터 없음	데이터 없음
Hayley Close	Head of Business Development	3.2yrs	데이터 없음	데이터 없음
Venkata Putcha	Head of Biostatistics	less than a year	데이터 없음	데이터 없음
Mark Middleton	Consultant & Member of Scientific Advisory Board	9.2yrs	데이터 없음	데이터 없음
Robert Jackson	Consultant & Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음

3.2yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: PYC 의 관리팀은 경험 ( 2.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Peter Sargent	CEO, COO & Director	less than a year	데이터 없음	데이터 없음
David Fell	Co-Founder & Member of Scientific Advisory Board	no data	UK£2.63k	데이터 없음
Mark Middleton	Consultant & Member of Scientific Advisory Board	9.2yrs	데이터 없음	데이터 없음
Robert Jackson	Consultant & Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Shalabh Kumar	Independent Non-Executive Director	2.1yrs	UK£23.67k	데이터 없음
Timothy Corn	Independent Non-Executive Director	2.5yrs	UK£20.00k	데이터 없음
James Millen	Non-Executive Chairman	8.4yrs	UK£138.61k	0.93% £ 13.2k

2.5yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: PYC 의 이사회는 경험(평균 재직 기간 2.2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Physiomics 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc

Less than half of directors are independent

Physiomics plc Announces Chief Executive Officer Changes

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Physiomics Plc, Annual General Meeting, Nov 21, 2023

Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics

Recent updates

Full year 2024 earnings: Revenues miss analyst expectations

New minor risk - Financial data availability

New major risk - Shareholder dilution

Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc

Physiomics Plc Increases Revenue Expectation for the Year 2025

First half 2024 earnings released: UK£0.002 loss per share (vs UK£0.002 loss in 1H 2023)

Physiomics Plc to Report First Half, 2024 Results on Mar 07, 2024

New minor risk - Shareholder dilution

Less than half of directors are independent

Physiomics plc Announces Chief Executive Officer Changes

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Physiomics Plc, Annual General Meeting, Nov 21, 2023

Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

New minor risk - Financial data availability

New minor risk - Financial data availability

Physiomics plc Appoints Dr. Peter Sargent as Chief Operating Officer

New minor risk - Shareholder dilution

First half 2023 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in 1H 2022)

Physiomics plc Announces Change of Job Title of Dr. Christophe Chassagnole from Chief Operating Officer to Chief Scientific Officer

Physiomics Plc Announces Successful Completion of its PARTNER Study

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Physiomics Plc, Annual General Meeting, Nov 22, 2022

Third quarter 2022 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 3Q 2021)

Physiomics Plc to Report Fiscal Year 2022 Results on Sep 29, 2022

Physiomics Plc Appoints Shalabh Kumar as Independent Non-Executive Director

Less than half of directors are independent

Physiomics plc Announces Board Changes, Effective April 1, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Physiomics Plc to Report First Half, 2022 Results on Mar 07, 2022

Physiomics plc Announces Board Changes

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Full year 2021 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in FY 2020)

Physiomics plc Announces Earnings Guidance for the Year Ending June 30, 2021

First half 2021 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 1H 2020)

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

TRHC’s DoseMeRx Partners with Physiomics to Provide Precision Dosing for Oncology Medications

Physiomics Plc Announces Approval of NIHR-funded PARTNER Study

Full year earnings released - UK£0.00087 loss per share

Annual earnings released: Earnings beat expectations, revenue disappoints

Physiomics plc Receives Award from Bicycle Therapeutics plc and Merck KGaA to Further Contracts of Undisclosed Value for Projects

Full year earnings released - UK£0.00087 loss per share

Physiomics Plc to Report Fiscal Year 2020 Results on Sep 30, 2020

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령